0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Ophthalmology Clinical Challenge |  February 01, 2013
Intractable Graves Ophthalmopathy?—Quiz Case
Francisco Castillo, MD; James A. Garrity, MD; Daniel J. Kravitz, MD
JAMA Ophthalmol. 2013;131(2):269. doi:10.1001/jamaophthalmol.2013.2264a.
JAMA Ophthalmology Clinical Challenge |  February 01, 2013
Intractable Graves Ophthalmopathy?—Diagnosis
JAMA Ophthalmol. 2013;131(2):270. doi:10.1001/jamaophthalmol.2013.2264b.
Clinical Sciences |  December 01, 2012
Eyebrow Tissue Expansion:  An Underappreciated Entity in Thyroid-Associated Orbitopathy
Louis M. Savar, MD; Ravi M. Menghani, MD; Kelvin K. Chong, MD; et al.
Arch Ophthalmol. 2012;130(12):1566-1569. doi:10.1001/archophthalmol.2012.2543.
Special Article |  March 14, 2011 FREE
Rundle and His Curve
George B. Bartley, MD
Arch Ophthalmol. 2011;129(3):356-358. doi:10.1001/archophthalmol.2011.29.
Research Letters |  December 01, 2010 FREE
Clinical Characterization and Immunopathologic Features of Sclerosing Dacryoadenitis and Riedel Thyroiditis
Frederick A. Jakobiec, MD, DSc; Rebecca C. Stacy, MD, PhD; Mark P. Hatton, MD
Arch Ophthalmol. 2010;128(12):1626-1628. doi:10.1001/archophthalmol.2010.299.
Small Case Series |  January 01, 2010 FREE
Idiopathic Orbital Inflammation and Graves Ophthalmopathy
Ward R. Bijlsma, MD; Rachel Kalmann, MD, PhD
Arch Ophthalmol. 2010;128(1):131-132. doi:10.1001/archophthalmol.2009.324.
Clinical Sciences |  September 14, 2009 FREE
Development of Criteria for Evaluating Clinical Response in Thyroid Eye Disease Using a Modified Delphi Technique
Raymond S. Douglas, MD, PhD; Angelo Tsirbas, MD; Mark Gordon, JD, MA; et al.
Arch Ophthalmol. 2009;127(9):1155-1160. doi:10.1001/archophthalmol.2009.232.
Clinical Sciences |  December 01, 2007 FREE
Oxidative Stress Change by Systemic Corticosteroid Treatment Among Patients Having Active Graves Ophthalmopathy
Chieh-Chih Tsai, MD; Shu-Ching Kao, MD; Ching-Yu Cheng, MD, MPH; et al.
Arch Ophthalmol. 2007;125(12):1652-1656. doi:10.1001/archopht.125.12.1652.
Laboratory Sciences |  October 01, 2006 FREE
Altered Tear Composition in Smokers and Patients With Graves Ophthalmopathy
Glynn R. C. Baker, MBBCh; Mike Morton, PhD; Rukshala S. Rajapaska, MBBCh; et al.
Arch Ophthalmol. 2006;124(10):1451-1456. doi:10.1001/archopht.124.10.1451.
Correspondence |  March 01, 2006
Graves Ophthalmopathy and Mood Disturbance
Kenneth S. C. Yuen, MRCS; Arthur C. K. Cheng, FRCS; Wai-Man Chan, FRCP, FRCS(Edin), FCOphth(HK)
Arch Ophthalmol. 2006;124(3):426-427. doi:10.1001/archopht.124.3.426-c.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  May 15, 2013
Factors That Influence Parathyroid Hormone Half-life:  Determining if New Intraoperative Criteria Are Needed
Andrew J. Leiker, BS; Tina W. F. Yen, MD, MS; Dan C. Eastwood, MS; et al.
JAMA Surgery
Invited Critique  |  May 15, 2013
Intraoperative Parathyroid Hormone Criteria: The Quest for Perfection:  Comment on “Factors That Influence Parathyroid Hormone Half-life”
Kelly L. McCoy, MD; Sally E. Carty, MD
JAMA
Editorial  |  April 10, 2013
Molecular Testing in Thyroid Cancer:  BRAF Mutation Status and Mortality
Anne R. Cappola, MD, ScM; Susan J. Mandel, MD, MPH
JAMA
Original Contribution  |  April 10, 2013
Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
Mingzhao Xing, MD, PhD; Ali S. Alzahrani, MD; Kathryn A. Carson, ScM; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems